Global Anal Cancer Market Size, Share, and COVID-19 Impact Analysis, By Treatment Type (Radiation Therapy, Surgery, Chemotherapy, and Immunotherapy), By End-User (Research & Academic Institutes, Long-term Care Centers, Hospitals & Clinics, and Pharmacies), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021– 2030

Industry: Healthcare

RELEASE DATE Oct 2022
REPORT ID SI1184
PAGES 240
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Treatment Type
      2. Market Attractiveness Analysis By End Users
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing prevalence of sexually transmitted diseases and anal cancer
    3. Restraints
      1. Side effects of chemotherapy
    4. Opportunities
      1. Increase in research and development
    5. Challenges

5.5.1. High cost of Treatment

  1. Global Anal Cancer Market Analysis and Projection, By Treatment Type
    1. Segment Overview
    2.  Radiation Therapy
    3. Surgery
    4. Chemotherapy
    5. Immunotherapy
  2. Global Anal Cancer Market Analysis and Projection, By End Users
    1.  Segment Overview
    2. Research & Academic Institutes
    3. Long-term Care Centers
    4. Hospitals & Clinics
    5. Pharmacies
  3. Global Anal Cancer Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Anal Cancer Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Anal Cancer Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
    2. Sanofi
  6. Abbvie Inc. (Allergan)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  7. AstraZeneca plc
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  8. Johnson & Johnson Services, Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  9.  GlaxoSmithKline plc
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  10. Pfizer Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  11.  Advaxis Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  12.  Spectrum Pharmaceuticals, Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  13. Merck & Co., Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  14.  Bayer AG
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis

List of Table

  1. Global Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  2. Global Radiation Therapy Anal Cancer Market, By Region, 2021-2030(USD Billion)
  3. Global Surgery Anal Cancer Market, By Region, 2021-2030(USD Billion)
  4. Global Chemotherapy Anal Cancer Market, By Region, 2021-2030(USD Billion)
  5. Global Immunotherapy Anal Cancer Market, By Region, 2021-2030(USD Billion)
  6. Global Anal Cancer Market, By End Users Type, 2021-2030(USD Billion)
  7. Global Research & Academic Institutes Anal Cancer Market, By Region 2021-2030(USD Billion)
  8. Global Long-term Care Centers Anal Cancer Market, By Region, 2021-2030(USD Billion)
  9. Global Hospitals & Clinics Anal Cancer Market, By Region, 2021-2030(USD Billion)
  10. Global Pharmacies Anal Cancer Market, By Region, 2021-2030(USD Billion)
  11. Global Anal Cancer Market, By Region, 2021-2030(USD Billion)
  12. North America Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  13. North America Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  14. U.S. Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  15. U.S. Anal Cancer Market, By End Users, 2021-2030(USD Billion) 
  16. Canada Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  17. Canada Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  18. Mexico Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  19. Mexico Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  20. Europe Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  21. Europe Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  22. Germany Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  23. Germany Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  24. France Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  25. France Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  26. U.K. Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  27. U.K. Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  28. Italy Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  29. Italy Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  30. Spain Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  31. Spain Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  32. Asia Pacific Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  33. Asia Pacific Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  34. Japan Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  35. Japan Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  36. China Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  37. China Anal Cancer Market, By End Users, 2021-2030(USD Billion) 
  38. India Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  39. India Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  40. South America Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  41. South America Anal Cancer Market, By End Users, 2021-2030(USD Billion)  
  42. Brazil Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  43. Brazil Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  44. The Middle East and Africa Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  45. The Middle East and Africa Anal Cancer Market, By End Users, 2021-2030(USD Billion) 
  46. UAE Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  47. UAE Anal Cancer Market, By End Users, 2021-2030(USD Billion)
  48. South Africa Anal Cancer Market, By Treatment Type, 2021-2030(USD Billion)
  49. South Africa Anal Cancer Market, By End Users, 2021-2030(USD Billion) 

 

List of Figures 

  1. Global Anal Cancer Market Segmentation
  2. Anal Cancer Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Anal Cancer Market
  9. Top Winning Strategies, 2021-2030
  10. Top Winning Strategies, By Development, 2021-2030(%)
  11. Top Winning Strategies, By Company, 2021-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers: Anal Cancer Market
  20. Anal Cancer Market Segmentation, By Treatment Type
  21. Anal Cancer Market For Radiation Therapy, By Region, 2022-2030 ($Billion)
  22. Anal Cancer Market For Surgery, By Region, 2022-2030 ($Billion)
  23. Anal Cancer Market For Chemotherapy, By Region, 2022-2030 ($Billion)
  24. Anal Cancer Market For Immunotherapy, By Region, 2022-2030 ($Billion)
  25. Anal Cancer Market Segmentation, By End Users
  26. Anal Cancer Market For Research & Academic Institutes, By Region, 2022-2030 ($Billion)
  27. Anal Cancer Market For Long-term Care Centers, By Region, 2022-2030 ($Billion)
  28. Anal Cancer Market For Hospitals & Clinics, By Region, 2022-2030 ($Billion)
  29. Anal Cancer Market For Pharmacies, By Region, 2022-2030 ($Billion)
  30. Procter & Gamble: Net Sales, 2021-2030 ($Billion)
  31. Procter & Gamble: Revenue Share, By Segment, 2022 (%)
  32. Procter & Gamble: Revenue Share, By Region, 2022 (%)
  33. PHYTOMER: Net Sales, 2021-2030 ($Billion)
  34. PHYTOMER: Revenue Share, By Segment, 2022 (%)
  35. PHYTOMER: Revenue Share, By Region, 2022 (%)
  36. Deka Corporation: Net Sales, 2021-2030 ($Billion)
  37. Deka Corporation: Revenue Share, By Segment, 2022 (%)
  38. Deka Corporation: Revenue Share, By Region, 2022 (%)
  39. Johnson & Johnson: Net Sales, 2021-2030 ($Billion)
  40. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  41. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  42. Unilever Plc.: Net Sales, 2021-2030 ($Billion)
  43. Unilever Plc.: Revenue Share, By Segment, 2022 (%)
  44. Unilever Plc.: Revenue Share, By Region, 2022 (%)
  45. Kao Corporation: Net Sales, 2021-2030 ($Billion)
  46. Kao Corporation: Revenue Share, By Segment, 2022 (%)
  47. Kao Corporation: Revenue Share, By Region, 2022 (%)
  48. ZO Skin Health, Inc.: Net Sales, 2021-2030 ($Billion)
  49. ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
  50. ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
  51. L’Oreal Paris: Net Sales, 2021-2030 ($Billion)
  52. L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
  53. L’Oreal Paris: Revenue Share, By Region, 2022 (%)
  54. Shiseido Company Limited: Net Sales, 2021-2030 ($Billion)
  55. Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
  56. Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
  57. Estee Lauder Companies, Inc.: Net Sales, 2021-2030 ($Billion)
  58. Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
  59. Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies